Junior/PhD Researcher in Brain-Inspired Edge AI Processors Design the next generation of low-power AI accelerators for the edge Overview Imec Netherlands has established a world-leading track record on the design of novel sensors for human health
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)